An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis After Methotrexate or After 1 or 2 TNF Inhibitors from a U.S. Payer Perspective.
J Manag Care Spec Pharm
; 24(10): 1010-1017, 2018 Oct.
Article
in En
| MEDLINE
| ID: mdl-29897007
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Piperidines
/
Arthritis, Rheumatoid
/
Pyrimidines
/
Pyrroles
/
Biological Products
/
Methotrexate
/
Tumor Necrosis Factor-alpha
/
Drug Costs
/
Antirheumatic Agents
/
Protein Kinase Inhibitors
Type of study:
Diagnostic_studies
/
Health_economic_evaluation
/
Prognostic_studies
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
J Manag Care Spec Pharm
Year:
2018
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
United States